Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307 Life Science
Donald Trump announces ‘very big day’ in US-EU trade war as European leaders agree to resolve issues Others, Technology